Home  >  Products  >  B4GALNT2 (beta-1,4-N-acetyl-galactosaminyl transferase 2 ) Blocking Peptide (the N terminal of B4GALNT2)(100ug)
B4GALNT2 (beta-1,4-N-acetyl-galactosaminyl transferase 2 ) Blocking Peptide (the N terminal of B4GALNT2)(100ug)

B4GALNT2 (beta-1,4-N-acetyl-galactosaminyl transferase 2 ) Blocking Peptide (the N terminal of B4GALNT2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-B4GALNT2 Antibody (ARP67019_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67019
Size: 100ug
Weight: 62kDa
Gene: 124872
Format: Lyophilized powder
Target: B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen.
Alternative names: B4GALT; GALGT2; MGC142235; MGC142237
See Full Product Listings >